Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #736

    Exciting E L

    1 Reply Last reply
    0
    • P Offline
      P Offline
      Peree
      wrote on sidst redigeret af
      #737

      Hvor ser i næste modstand?

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #738

        around 2140 was an area of interest in the past, but on the way down we just cut through it as warm butter....

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #739

          2182 was the last small high, would be nice to break above that. 2029 was really small resistance, but would like to stay above now

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #740

            2148: https://www.proinvestor.com/boards/86703/Teknisk-analyse-af-Genmab

            1 Reply Last reply
            0
            • JørgenVarnæsJ Offline
              JørgenVarnæsJ Offline
              JørgenVarnæs
              wrote on sidst redigeret af
              #741

              Gad vide, om der findes +100 point dage, ligesom vi har oplevet flere -100 dage her på det sidste?

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #742

                do you really need someone else to answer that question for you JV? 😉

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #743

                  AACR21
                  1574 - Preclinical evaluation of epcoritamab combined with standard of care therapies for the treatment of B-cell lymphomas https://www.abstractsonline.com/pp8/#!/9325/presentation/2679

                  1 Reply Last reply
                  0
                  • JørgenVarnæsJ Offline
                    JørgenVarnæsJ Offline
                    JørgenVarnæs
                    wrote on sidst redigeret af
                    #744

                    Indeed I do - I keep searching but come up empty handed every time

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #745

                      lol

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #746

                        AACR21 1846 - DuoBody-CD40×4-1BB (GEN1042) induces dendritic-cell maturation and enhances T-cell activation and effector functions in vitro by conditional CD40 and 4-1BB agonist activity https://www.abstractsonline.com/pp8/#!/9325/presentation/2903

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #747

                          Uğur Şahin co-author

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #748

                            1048 - Targeting BCL-2 and CD38 in models of acute myeloid leukemia reduces tumour burden https://www.abstractsonline.com/pp8/#!/9325/presentation/1980 "This data supports that combination treatment with Venetoclax and Daratumumab could have an important clinical application in the treatment of AML."

                            1 Reply Last reply
                            0
                            • DarvinD Offline
                              DarvinD Offline
                              Darvin
                              wrote on sidst redigeret af
                              #749

                              Ja det er lidt træls at det som regel tager længere tid at kravle opad end at springe nedad 🙂

                              1 Reply Last reply
                              0
                              • DarvinD Offline
                                DarvinD Offline
                                Darvin
                                wrote on sidst redigeret af
                                #750

                                Genmab er jo ellers i god form 😉

                                1 Reply Last reply
                                0
                                • R Offline
                                  R Offline
                                  Raun
                                  wrote on sidst redigeret af
                                  #751

                                  Jeg er nu ikke helt overbevist endnu, at vi har fundet en bund.... Genmab har bare fulgt det generelle marked igennem de seneste dage...

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #752

                                    953 - Efficacy of amivantamab, a bispecific EGFR/MET antibody, correlates with EGFR expression and signaling in NSCLC models with wild-type EGFR https://www.abstractsonline.com/pp8/#!/9325/presentation/2464

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #753

                                      anybody heard anything from the Investor Events Genmab joined this week? Carnegie ,
                                      HC Wainwright ,
                                      Barclays?

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #754

                                        No

                                        1 Reply Last reply
                                        0
                                        • nohopeN Offline
                                          nohopeN Offline
                                          nohope
                                          wrote on sidst redigeret af
                                          #755

                                          Hvis nu alle havde støttet op om forbuddet mod at sælge aktier billigere end man selv havde købt dem..

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger